NCT00002250已完成1 期
A Phase I Study of Recombinant Human CD4 Immunoglobulin G (rCD4-lgG) in Patients With HIV-Associated Immune Thrombocytopenic Purpura
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 试验地点
- 2
研究概览
简要总结
To test the effectiveness of recombinant human CD4 Immunoglobulin G (CD4-IgG) in the treatment of HIV-associated immune thrombocytopenic purpura in patients with all levels of HIV infection.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (2)
Loading locations...
相似试验
已完成
1 期
A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4 Immunoglobulin (rCd4-IgG) Administered by Intravenous Bolus in Patients With AIDS and AIDS Related ComplexHIV InfectionsNCT00000675National Institute of Allergy and Infectious Diseases (NIAID)60
已完成
4 期
Study of Combined Therapy IVIG-SN 10% and Acetylsalicylic Acid in Kawasaki DiseaseKawasaki DiseaseNCT04003844Green Cross Corporation45
已完成
2 期
Recombinant Human IL-4 Receptor Used in Treatment of AsthmaAsthmaNCT00017693National Institute of Allergy and Infectious Diseases (NIAID)62
已完成
不适用
A Phase I Study of Recombinant CD4(rCD4) in Patients With AIDS and AIDS-Related ComplexHIV InfectionsNCT00002005Genentech, Inc.
已完成
1 期
A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4-Immunoglobulin G (rCD4-IgG) Administered by Intravenous Bolus Injection in Combination With Oral Zidovudine in Patients With AIDS and AIDS-Related ComplexHIV InfectionsNCT00000976National Institute of Allergy and Infectious Diseases (NIAID)40